Suppr超能文献

一氧化氮作为比沙可啶和酚酞泻药作用的介质:一氧化氮合酶的诱导

Nitric oxide as a mediator of bisacodyl and phenolphthalein laxative action: induction of nitric oxide synthase.

作者信息

Gaginella T S, Mascolo N, Izzo A A, Autore G, Capasso F

机构信息

Department of Experimental Pharmacology, University of Naples, Federico II, Italy.

出版信息

J Pharmacol Exp Ther. 1994 Sep;270(3):1239-45.

PMID:7523656
Abstract

Bisacodyl and phenolphthalein are diphenylmethane laxatives that have effects on intestinal water and electrolyte transport and smooth muscle contractility. Nitric oxide (NO) is produced in the intestine, where it stimulates electrolyte secretion and relaxes smooth muscle. Therefore, we studied in rats the effect of these laxatives on diarrhea, fluid transport in vivo, gastrointestinal transit and NO synthase activity in the absence and presence of inhibitors of NO synthesis. Both laxatives (50 mg/kg p.o.) produced diarrhea, which was delayed in onset by 25 mg/kg (i.p.) of the NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME). The L-NAME effect was reversed by the NO donor isosorbide-5-mononitrate (30-120 mg/kg i.p.). L-Arginine (600 and 1500 mg/kg i.p.) prevented the inhibitory effect of L-NAME on diarrhea. The laxatives evoked water and electrolyte secretion and enhanced the transit of a suspension of charcoal through the gastrointestinal tract. This was inhibited by L-NAME but not D-NAME. The inhibitor of inducible NO synthase, dexamethasone (0.03-0.3 mg/kg i.p.), prevented the effects of both laxatives on electrolyte and water transport. Stimulation by these drugs of NO synthase was also inhibited by dexamethasone. The results demonstrate that bisacodyl and phenolphthalein stimulate water and electrolyte secretion, promote transit of intraluminal contents and produce diarrhea in association with enhanced production of NO. Furthermore, it appears that the NO is derived principally from activation of an inducible form of NO synthase.

摘要

比沙可啶和酚酞是二苯甲烷类泻药,它们对肠道水和电解质转运以及平滑肌收缩性有影响。一氧化氮(NO)在肠道中产生,它刺激电解质分泌并使平滑肌松弛。因此,我们在大鼠中研究了这些泻药在不存在和存在NO合成抑制剂的情况下对腹泻、体内液体转运、胃肠运输以及NO合酶活性的影响。两种泻药(口服50mg/kg)均引起腹泻,而NO合酶抑制剂NG-硝基-L-精氨酸甲酯(L-NAME,腹腔注射25mg/kg)可延迟腹泻的发作。NO供体5-单硝酸异山梨酯(腹腔注射30-120mg/kg)可逆转L-NAME的作用。L-精氨酸(腹腔注射600和1500mg/kg)可预防L-NAME对腹泻的抑制作用。泻药引起水和电解质分泌,并增强了木炭悬浮液在胃肠道中的运输。这被L-NAME抑制,但不被D-NAME抑制。诱导型NO合酶抑制剂地塞米松(腹腔注射0.03-0.3mg/kg)可预防两种泻药对电解质和水转运的影响。地塞米松也抑制了这些药物对NO合酶的刺激作用。结果表明,比沙可啶和酚酞刺激水和电解质分泌,促进肠腔内内容物的运输,并与NO生成增加相关地产生腹泻。此外,似乎NO主要来源于诱导型NO合酶的激活。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验